1. Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. (December 2016) Authors: Ylstra, B.; Cordes, M.; Biesma, H.D.; Verheul, H.M.; Neerincx, M.; Koopman, M.; Punt, C.J.; Meijer, G.A.; Murphy, V.; Barat, A.; Betge, J.; Ebert, M.; Gaiser, T.; Fender, B.; Klinger, R.; Das, S.; Smeets, D.; Lambrechts, D.; Byrne, A.T.; Van Grieken, N.C.T. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗